H.P.M.C E-15/K4M/K100M

Get a Price/Quote

MOQ : 100 Kilograms

H.P.M.C E-15/K4M/K100M Trade Information

Minimum Order Quantity
100 Kilograms

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
1000 Kilograms Per Week

Delivery Time
5-10 Days

Packaging Details
Dram and Bag

Main Domestic Market
All India

About H.P.M.C E-15/K4M/K100M

H.P.M.C deliver exceptional flow properties and process capability as well as consistent modified release performance for matrix formulations. H.P.M.C will enable manufacturers to replace costly wet granulation in matrix tablet production with cost effective dry granulation and direct compression techniques.

Three direct compression grades of H.P.M.C are now available: K100 LV, K4M and K100M; chemically identical to current METHOCEL Premium products.

Versatile Applications in the Pharmaceutical Industry

H.P.M.C E-15/K4M/K100M is commonly employed as an excipient and controlled-release modifier in oral medications. Its viscoelastic nature allows precise manipulation of drug release rates, improving patient outcomes and compliance. The polymer's inert profile ensures safety and compatibility with an extensive range of active ingredients, making it indispensable in advanced pharmaceutical manufacturing.

Outstanding Physical and Chemical Properties

With a remarkable boiling point of 1101.5C and a unique melting point of 1.39C, H.P.M.C offers thermal stability essential for rigorous drug formulation processes. Its molecular composition supports consistent performance, while its water solubility facilitates ease of incorporation in various dosage forms. Suppliers and traders across India rely on its reliable quality and robust attributes in commercial production.

FAQ's of H.P.M.C E-15/K4M/K100M:

Q: How is H.P.M.C E-15/K4M/K100M typically used in pharmaceutical formulations?

A: H.P.M.C E-15/K4M/K100M serves as an excipient and controlled-release agent in oral medications, enabling precise control of drug dissolution and absorption rates, thereby optimizing therapeutic efficacy.

Q: What benefits does Hypromellose offer compared to other excipients?

A: Hypromellose is inert, highly compatible with many drugs, and offers exceptional control over drug release profiles, improving medication consistency and patient adherence while minimizing interaction risks.

Q: When should H.P.M.C E-15/K4M/K100M be incorporated into drug formulation processes?

A: Formulators typically use H.P.M.C during the development of oral dosages that require extended release, enhanced stability, or improved texture and processing for tablets and capsules.

Q: Where can pharmaceutical manufacturers source H.P.M.C E-15/K4M/K100M in India?

A: Manufacturers can procure H.P.M.C E-15/K4M/K100M from reputable suppliers and traders throughout India, which specialize in pharmaceutical-grade raw materials for commercial production.

Q: What is the process of incorporating Hypromellose into oral medicaments?

A: The integration involves dispersing the polymer into the medication mixture, where it acts as a binder, matrix former, or release modifier, tailored to achieve the desired therapeutic release profile.

Q: How does the viscoelastic nature of H.P.M.C E-15/K4M/K100M benefit drug formulations?

A: Its viscoelastic properties ensure tablets are resilient and maintain structural integrity during production, storage, and administration, enhancing the reliability and safety of oral medicines.

Tell us about your requirement